Literature DB >> 15706403

Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.

Kostas Stamatopoulos1, Chrysoula Belessi, Theodora Papadaki, Evangelia Kalagiakou, Niki Stavroyianni, Vassiliki Douka, Stavroula Afendaki, Riad Saloum, Aikaterini Parasi, Dimitra Anagnostou, Nikolaos Laoutaris, Athanasios Fassas, Achilles Anagnostopoulos.   

Abstract

The considerable heterogeneity in morphology, immunophenotype, genotype, and clinical behavior of splenic marginal zone lymphoma (SMZL) hinders firm conclusions on the origin and differentiation stage of the neoplastic cells. Immunoglobulin (IG) gene usage and somatic mutation patterns were studied in a series of 43 SMZL cases. Clonal IGHV-D-J rearrangements were amplified in 42/43 cases (4 cases carried double rearrangements). Among IGHV-D-J rearrangements, IGHV3 and IGHV4 subgroup genes were used with the highest frequency. Nineteen IGHV genes were unmutated (> 98% homology to the closest germline IGHV gene), whereas 27/46 were mutated. Clonal IGKV-J and IGLV-J gene rearrangements were amplified in 36/43 cases, including 31 IGKV-J (8/31 in lambda light-chain expressing cases) and 12 IGLV-J rearrangements; 9/31 IGKV and 6/12 IGLV sequences were mutated. IGKV-J and IGLV-J rearrangements used 14 IGKV and 9 IGLV different germline genes. Significant evidence for positive selection by classical T-dependent antigen was found in only 5/27 IGHV and 6/15 IGKV+IGLV mutated genes. These results provide evidence for the diverse B-cell subpopulations residing in the SMZ, which could represent physiologic equivalents of distinct SMZL subtypes. Furthermore, they indicate that in SMZL, as in other B cell malignancies, a complementarity imprint of antigen selection might be witnessed either by IGHV, IGKV, or IGLV rearranged sequences.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15706403      PMCID: PMC1431370          DOI: 10.2119/2005-00001.Stamatopoulos

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  54 in total

1.  Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells.

Authors:  H P Brezinschek; S J Foster; R I Brezinschek; T Dörner; R Domiati-Saad; P E Lipsky
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

2.  Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells.

Authors:  S J Foster; H P Brezinschek; R I Brezinschek; P E Lipsky
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

3.  The creation of diversity in the human immunoglobulin V(lambda) repertoire.

Authors:  O Ignatovich; I M Tomlinson; P T Jones; G Winter
Journal:  J Mol Biol       Date:  1997-04-25       Impact factor: 5.469

4.  Follicular lymphoma immunoglobulin kappa light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains.

Authors:  K Stamatopoulos; C Kosmas; T Papadaki; E Pouliou; C Belessi; S Afendaki; D Anagnostou; D Loukopoulos
Journal:  Br J Haematol       Date:  1997-01       Impact factor: 6.998

5.  Sequence analysis of rearranged IgVH genes from microdissected human Peyer's patch marginal zone B cells.

Authors:  D K Dunn-Walters; P G Isaacson; J Spencer
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

6.  Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes.

Authors:  D Zhu; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

7.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells.

Authors:  S S Sahota; R Leo; T J Hamblin; F K Stevenson
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

9.  Human autoantibody recognition of DNA.

Authors:  S M Barbas; H J Ditzel; E M Salonen; W P Yang; G J Silverman; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

Authors:  J D Marks; H R Hoogenboom; T P Bonnert; J McCafferty; A D Griffiths; G Winter
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

View more
  5 in total

1.  Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.

Authors:  Silvia Zibellini; Daniela Capello; Francesco Forconi; Paolo Marcatili; Davide Rossi; Sara Rattotti; Silvia Franceschetti; Elisa Sozzi; Emanuele Cencini; Roberto Marasca; Luca Baldini; Alessandra Tucci; Francesco Bertoni; Francesco Passamonti; Ester Orlandi; Marzia Varettoni; Michele Merli; Silvia Rizzi; Valter Gattei; Anna Tramontano; Marco Paulli; Gianluca Gaidano; Luca Arcaini
Journal:  Haematologica       Date:  2010-05-29       Impact factor: 9.941

2.  IMGT, the international ImMunoGeneTics information system: a standardized approach for immunogenetics and immunoinformatics.

Authors:  Marie-Paule Lefranc
Journal:  Immunome Res       Date:  2005-09-20

3.  IGK with conserved IGΚV/IGΚJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration.

Authors:  Chong Wang; Miaoran Xia; Xiaoping Sun; Zhiqiao He; Fanlei Hu; Lei Chen; Carlos E Bueso-Ramos; Xiaoyan Qiu; C Cameron Yin
Journal:  Oncotarget       Date:  2015-11-17

4.  Transcriptomic analysis of immune cells in a multi-ethnic cohort of systemic lupus erythematosus patients identifies ethnicity- and disease-specific expression signatures.

Authors:  Gaia Andreoletti; Cristina M Lanata; Laura Trupin; Ishan Paranjpe; Tia S Jain; Joanne Nititham; Kimberly E Taylor; Alexis J Combes; Lenka Maliskova; Chun Jimmie Ye; Patricia Katz; Maria Dall'Era; Jinoos Yazdany; Lindsey A Criswell; Marina Sirota
Journal:  Commun Biol       Date:  2021-04-21

5.  CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma.

Authors:  Gunhild Trøen; Abdirashid Warsame; Jan Delabie
Journal:  ISRN Oncol       Date:  2013-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.